CMAB801

N/A

Report date: 2023/01/07 17:46:07

Base Information

Drug NameCMAB801
Drug Alias NameCMAB801注射液CMAB-801
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Maibo Taike Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Maibo Taike Biotechnology Co Ltd
Inactive CompaniesTaizhou Mabtech Pharmaceutical Co Ltd
Active IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A